Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.
7d
GlobalData on MSNEli Lilly adds Alzheimer’s treatment options to LillyDirect telehealth platformThe platform features Healthgrades, a tool intended to connect Alzheimer's patients to experienced local clinicians.
Both EOAD and late onset Alzheimer’s are treated using the same medications, supportive therapies, and lifestyle modifications. Discuss treatment options for EOAD with a doctor. They can work ...
Research shows experimental anti-amyloid drug reduced cognitive symptom risk by 50% in people with rare genetic mutations ...
Worried about memory loss? Learn how to tell normal aging from dementia, spot early signs, and understand when to seek ...
Early-onset Alzheimer's advances quickly -- and the rapid decline is devastating. That's why researchers are racing to find ...
Determining the clinical stage of dementia can help ensure that the ... more confident and definitive diagnosis and clarifies options for treatment." Co-senior author Randall J.
Patients and caregivers The social, emotional and financial impact of Alzheimer's on patients and caregivers/family is devastating. Due to limited diagnostic and treatment options patients are ...
Eli Lilly is expanding its menu of direct-to-consumer healthcare offerings. | Eli Lilly is expanding its menu of ...
New research shows Alzheimer's blood tests are 90% accurate for white patients but only 73% for Black patients, raising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results